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OBJECTIVES The purpose of this study was to examine the relationship between annual operator volume
and outcomes of percutaneous coronary interventions (PCIs) using contemporaneous data.
BACKGROUND The 1997 American College of Cardiology (ACC)/American Heart Association task force
based their recommendation that interventionists perform $75 procedures per year to
maintain competency in PCI on data collected largely in the early 1990s. The practice of
interventional cardiology has since changed with the availability of new devices and drugs.
METHODS Data were collected from 1994 through 1996 on 15,080 PCIs performed during 14,498
hospitalizations by 47 interventional cardiologists practicing at the five high volume (.600
procedures per hospital per year) hospitals in northern New England and one Massachusetts-
based institution that support these procedures. Operators were categorized into terciles based
on their annualized volume of procedures. Multivariate regression analysis was used to control
for case-mix. In-hospital outcomes included death, emergency coronary artery bypass graft
surgery (eCABG), non-emergency CABG (non-eCABG), myocardial infarction (MI), death
and clinical success ($1 attempted lesion dilated to ,50% residual stenosis and no death,
CABG or MI).
RESULTS Average annual procedure rates varied across terciles from low 5 68, middle 5 115 and
high 5 209. After adjusting for case-mix, clinical success rates were comparable across terciles
(low, middle and high terciles: 90.9%, 88.8% and 90.7%, ptrend 5 0.237), as were all the
adverse outcomes including death (low-risk patients 5 0.45%, 0.41%, 0.71%, ptrend 5 0.086;
high-risk patients 5 5.68%, 5.99%, 7.23%, ptrend 5 0.324), eCABG (1.74%, 2.05%, 1.75%,
ptrend 5 0.733) and MI (2.57%, 1.90%, 1.86%, ptrend 5 0.065).
CONCLUSIONS Using current data, there is no significant relationship between operator volumes averaging
$68 per year and outcomes at high volume hospitals. Future efforts should be directed at
determining the generalizability of these results. (J Am Coll Cardiol 1999;34:1471–80) ©
1999 by the American College of Cardiology
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In the last four years, several studies have evaluated the
relationship between the volume of interventions and out-
comes for patients undergoing percutaneous coronary inter-
ventions (PCIs) (1–14). They established that there is an
inverse relationship between the annual volume of PCIs and
the incidence of procedural complications at both the
institutional level (2,4–6,10–14) and the operator level
(1,3–9). These findings prompted the American College of
See page 1481
Cardiology (ACC) to include in their most recent PCI
guidelines (15) a recommendation that hospitals should
have a volume of at least 400 procedures per year and
operators a volume of 75 procedures per year to help insure
good outcomes. The studies used to support this recom-
mendation relied upon data from the early 1990s, and since
that time, the practice of interventional cardiology has
changed.
The strongest relationship between volume and outcomes
for PCIs has been for emergency coronary artery bypass
graft surgery (eCABG). In general, at both the institutional
and operator level, higher volumes have been associated
with significant reductions in the need for postprocedure
eCABG. However, recent observational studies have shown
that stent use has reduced the need for eCABG following
PCI (16–20). With the Federal Drug Administration’s
approval of stents for a broader range of indications and a
strategy of high pressure inflations to reduce the need for
aggressive antithrombotic regimens, the use of stents has
seen exponential growth. In addition, there have been other
changes in practice patterns which might be expected to
improve outcomes following PCIs that include the use of
lower profile balloons, better guiding catheters and new
antiplatelet agents.
Not only has equipment and drug therapy used for PCIs
changed over the last several years, but the cumulative
experience of individual operators has increased and there
has been a growing emphasis on efforts in quality assessment
and improvement. Given all these factors, we thought it
appropriate to re-evaluate the relationship between operator
volume and outcomes using more current data. Therefore,
we used our prospective, regional, clinical database of
consecutive PCIs to examine the question of whether
operator volume continues to be related to in-hospital
clinical success or adverse outcomes in six high volume
hospitals in the more modern era of interventional cardiol-
ogy.
METHODS
The Northern New England Cardiovascular Disease Study
Group is a voluntary research consortium composed of
clinicians, research scientists and hospital administrators at
the five institutions in Maine, New Hampshire and Ver-
mont who are the sole providers of coronary revasculariza-
tion in the region, and one Massachusetts-based institution.
The intent of the group is to foster continuous improvement
in the quality of care of patients with cardiovascular disease
in northern New England through the pooling of process
and outcome data and the timely feedback of data to
clinicians (21,22).
Between January 1, 1994 and December 31, 1996, data
were collected on 15,331 consecutive hospitalizations for a
PCI. After eliminating cases associated with three operators
performing ,5 interventions per year (i.e., two interven-
tional fellows in transition to new jobs and one physician
who performed 13 procedures during two, three month
clusters early in the three year experience and who had not
performed any procedures during the last 15 months of the
study), physicians performing any intervention outside the
region and the few unattributed cases, there remained data
on 14,498 hospitalizations, contributed by 47 intervention-
ists performing 15,080 PCIs, which became the study
cohort. Annualized procedure rates for each operator were
calculated by determining the number of months during the
study period in which a physician was recorded as a primary
operator and the number of procedures they performed
during that time period and standardizing that relationship
to 12 months. After examining scatterplots of annual
operator volume versus adverse outcomes and seeing no
apparent relationship, operators were ranked based on their
annualized rates and then categorized into low, middle or
high volume terciles in an effort to maximize the power of
detecting a relationship. The mean number of months
during which study physicians contributed data was 30
(range 6 to 36 months, median 36 months).
The following information was collected for every PCI:
1) site and primary operator;
2) demographic data: patient age, gender, height, weight;
3) medical history: previous coronary artery bypass graft
surgery (CABG), PCI or myocardial infarction (MI),
family history of premature coronary artery disease, the
presence of congestive heart failure, hypertension,
treated diabetes, current smoking, hypercholesterolemia,
chronic obstructive pulmonary disease, peripheral vascu-
lar disease, cerebrovascular disease, renal failure, baseline
creatinine;
4) primary indication for PCI: stable angina, unstable
Abbreviations and Acronyms
ACC 5 American College of Cardiology
CABG 5 coronary artery bypass graft
CI 5 confidence interval
CPK 5 creatine phosphokinase
eCABG 5 emergency coronary artery bypass graft
MI 5 myocardial infarction
OR 5 odds ratio
PCI 5 percutaneous coronary intervention
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angina, postinfarction angina, postinfarction anatomy,
primary therapy for acute MI, cardiogenic shock;
5) priority at PCI: emergent, urgent, nonurgent;
6) therapy before during and after the procedure: intrave-
nous heparin, intravenous nitroglycerin, thrombolytic
therapy, insertion of an intraaortic balloon pump;
7) cardiac anatomy and function: percent stenosis of left
main coronary artery, number of other diseased (.70%
stenosis) native coronary vessels (left anterior descend-
ing, right or circumflex), dominance, number of bypass
grafts (distal anastomoses), ejection fraction, left ventric-
ular end diastolic pressure;
8) PCI procedure information: location of the lesions
attempted [using the Coronary Artery Surgery Study
map, (23)], pre- and poststenosis, lesion type (24) A, B1,
B2 or C, location of collateral vessels, device use includ-
ing balloon, directional atherectomy, transluminal ex-
traction, rotational atherectomy, laser, or stent;
9) outcomes (all in-hospital): death, eCABG, non-
eCABG, or new MI, defined as chest pain, diaphoresis,
dyspnea or hypotension associated with the development
of new Q-waves or ST-TW changes and a rise in
creatine phosphokinase (CPK) to at least twice normal
with a positive CPK-MB. Clinical success was defined as
$1 attempted lesion(s) successfully dilated and no ad-
verse clinical outcomes. Adverse clinical outcomes in-
cluded any in-hospital death, eCABG, non-eCABG or
postprocedure MI.
The number of patients in the data set were verified using
hospital discharge data supplemented by cardiac catheter-
ization laboratory logs. Any missing information was ob-
tained. The outcomes of death and CABG were validated
from the hospital discharge data set and review of the
medical record. Myocardial infarction as an outcome was
not independently validated.
All analyses were carried out using Statistical Analysis
Software (SAS Institute Inc., Cary, North Carolina), Release
6.11 (25) or STATA Statistical Software, Release 5.0
(STATA Corp Inc., College Station, Texas) (26). Logistic
regression (27) was used to assess whether changes in case-mix
differed across terciles of operator volume (ptrend), except for
the ordinal variables of indication, priority and lesion type
where a Mantel-Haenszel chi-square statistic was used. For
several patients, disease and treatment characteristics had
missing data. Those with less than 2% missing values were
coded as “not present.” Others, particularly the treatment
variables of intravenous nitroglycerin, thrombolytics and in-
traaortic balloon pumping were coded as “not present” under
the assumption that if they had been used, it would have been
recorded.
Multivariate models were used to adjust for differences in
case-mix and severity of illness across terciles of operator
volume when comparing outcomes. All variables demon-
strating a univariate association with the dependent variable
of interest at p , 0.10 (without adjustment for multiple
comparisons) were considered potential independent vari-
ables for inclusion in the multivariate analyses. Much of the
data was naturally discrete. Continuous variables were
examined to determine the categorization that best related
them to the dependent variables. To determine whether
tercile of operator volume was independently associated
with outcomes, tercile was forced into the multivariate
models. Tercile was used as an ordinal variable to test for a
linear relationship between volume and outcomes and re-
ported as a “p of trend.” It was also parameterized using
dummy variables, with the low tercile group as a referent
category, to test the independent relationship of each
volume tercile to outcome, and reported as confidence
intervals (CIs) around the adjusted point estimate of out-
come. For death, a separate model was developed for
patients at higher risk for an adverse outcome, defined as
those undergoing an emergency procedure or being treated
for an MI or cardiogenic shock, because previous work using
a general model for death had shown that the relationship
between observed and expected mortality was weakest for
patients at highest risk (28). Direct standardization (29) was
used to calculate adjusted rates.
RESULTS
Among the 47 interventionists, average annualized operator
volume varied from a low of 22 to a high of 370 cases per
year (Table 1). Across terciles of operator volume, the
median number of cases per year increased from 75 (range
22 to 84) to 119 (range 88 to 129) to 194 (range 138 to 370).
Lower tercile operators performed 14.4% of all procedures
whereas middle tercile operators performed 27.9% and high
tercile operators performed 57.7% of procedures.
Patient, disease and procedural characteristics by tercile of
operator volume are shown in Tables 2 and 3. As operator
volume increased, there was a trend toward patients being
older, having more diabetes, vascular disease and renal
failure, having undergone previous revascularization and
having more three-vessel and left main disease. High tercile
operators were more likely to be intervening on patients
requiring emergency procedures and in cardiogenic shock.
Regardless of tercile, operators chose to intervene on a
comparable number of lesions. High tercile operators were
more likely to attempt ACC type B lesions and to work in
bypass grafts. High tercile operators were also more likely to
Table 1. Annualized Rates of Procedures by Terciles*
Terciles
Low Middle High
Operators per tercile (n) 15 16 16
Patients (n) 2,082 4,046 8,370
Mean (cases/yr) 68 115 209
Median (cases/yr) 75 119 194
Range (cases/yr) 22–84 88–129 138–370
*Rates are corrected for the number of months an operator contributed data.
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use rotational atherectomy and less likely to use a stent than
lower volume operators.
Crude rates of outcomes (with 95% CIs) are shown in
Table 4. After adjusting for case-mix and severity of illness
(see Appendix A for logistic models) there was no difference
in the rates of clinical success across terciles of operator
volume (90.9% low vs. 88.8% middle vs. 90.7% high volume
terciles; ptrend 5 0.237). The same was true for rates of all
the adverse outcomes (Table 5) except for non-eCABG,
which increased from 0.44% in the low volume tercile to
0.80% and 0.90% in the middle and high volume terciles,
respectively, a trend of borderline significance (ptrend 5
0.051), and MI, which decreased marginally between the
low versus the middle and high volume terciles, though
there was marked overlap among the CIs for the point
estimates.
To determine whether the influx of new providers into
the region influenced our results, we limited the analysis to
only those interventionists who contributed to the previous
study (9). Our findings did not change. Within each tercile
operators were imperfectly distributed across sites. Site was
therefore entered into the multivariate model to determine
whether the results were confounded by site. They were not.
The use of coronary stents grew markedly over the time
period of this study (Fig. 1), and, therefore, we examined
their relationship to our findings. After adjusting for case-
mix, the use of a coronary stent was associated with a lower
likelihood of CABG (odds ratio [OR] 5 0.72, 95% CI
0.58, 0.91), eCABG (OR 5 0.91, 95% CI 0.66, 1.24),
non-eCABG (OR 5 0.36, 95% CI 0.19, 0.70) and death in
high risk patients (OR 5 0.48, 95% CI 0.21, 1.10), no
change in the likelihood of death in low risk patients (OR 5
1.00, 95% CI 0.58, 1.73) and an increased likelihood of
clinical success (OR 5 1.19, 95% CI 1.03, 1.37), though not
all these ORs reached statistical significance. Because they
are used frequently in the setting of acute closures, stents
were associated with an increased likelihood of an MI
(OR 5 1.84, 95% CI 1.43, 2.37). When stent was entered
into the multivariate model, the relationship between tercile
of operator volume and outcome did not change and
remained insignificant.
DISCUSSION
Our major finding is that in northern New England from
1994 through 1996, the average annual volume of pro-
cedures performed by interventionists was not signifi-
cantly related to the rates of successful or unsuccessful
procedures. Even after adjusting for case-mix, the rates of
clinical success and adverse outcomes were comparable
Table 2. Clinical Characteristics by Terciles of Annual Operator Procedure Rates
Characteristic
Terciles
p-Trend*
Low
(n 5 2,082)
Middle
(n 5 4,046)
High
(n 5 8,370)
Age (mean) 60.4 61.0 61.8 , 0.001
Female (%) 31.4 32.3 32.4 0.146
Body surface area (m2) 1.96 1.97 1.96 0.069
Creatinine (mg/dL) 1.0 1.1 1.1 0.006
Comorbidities (%)
Diabetes 19.6 22.2 22.5 0.013
Vascular disease 8.7 9.9 10.2 0.060
COPD 9.4 7.7 9.2 0.459
Renal failure 1.7 1.6 2.2 0.031
Prior cardiac history (%)
Previous MI 23.1 26.5 25.8 0.065
Previous PCI 24.0 29.0 30.1 , 0.001
Previous CABG 10.3 14.2 15.6 , 0.001
Congestive heart failure 5.5 5.2 5.2 0.563
Cardiac anatomy and function (%)
Three-vessel disease 9.3 12.3 12.3 0.002
$50% Left main disease 2.0 2.2 3.3 , 0.001
EF ,40% 4.8 3.7 5.2 0.038
Preprocedure treatment (%)
Heparin 58.5 59.0 55.5 , 0.001
Intravenous nitroglycerin 25.3 23.6 26.2 0.048
Thrombolytic 9.6 6.9 9.5 0.074
IABP 0.3 0.3 0.5 0.160
*ANOVA for continuous variables.
ANOVA 5 analysis of variance; CABG 5 coronary artery bypass grafting surgery; COPD 5 chronic obstructive pulmonary
disease; EF 5 ejection fraction; IABP 5 intraaortic balloon pump; MI 5 myocardial infarction; PCI 5 percutaneous coronary
intervention.
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across terciles of operator volume. Though there were
possible trends between the outcomes of non-eCABG
and MI and terciles of operator volume, they should be
interpreted with caution as there may be a lower thresh-
old for recommending surgical revascularization among
higher tercile operators than among lower tercile opera-
tors, MI was not a validated outcome and its assessment
may differ by tercile of operator volume, and these are
only two associations among many that were tested.
The previous study. These results differ from what we
previously reported using 1990–1993 data (9). During that
time period there was a positive relationship between
operator volume and success but a negative association
Table 3. Indication, Priority and Procedural Characteristics by Terciles of Annual Operator
Procedure Rates
Characteristic
Terciles
p-Trend*
Low
(n 5 2,082)
Middle
(n 5 4,046)
High
(n 5 8,370)
Priority (%)
Emergent 7.2 9.1 9.5 , 0.001
Urgent 52.2 53.9 56.8
Nonurgent 40.7 37.0 33.8
Indication (%)
Stable angina 23.0 21.6 21.7 0.099
Unstable angina 70.4 70.8 71.3
Primary therapy for MI 5.2 5.0 4.2
Cardiogenic shock 0.3 0.3 0.8
Other 1.1 2.3 2.0
Lesion characteristics (%)
Lesions attempted (mean) 1.3 1.4 1.4 0.032
Proximal LAD attempted 18.8 17.5 17.1 0.082
Bypass graft attempted 3.9 6.4 6.1 0.003
Lesions types
A 44.1 43.7 31.0 , 0.001
B1 32.6 34.3 44.7
B2 14.8 15.0 15.4
C 8.5 7.0 8.9
Devices (%)
Stent used 25.4 26.5 18.1 , 0.001
Directional atherectomy 6.3 3.6 8.0 , 0.001
Rotational atherectomy 0.6 2.6 5.6 , 0.001
*ANOVA for continuous variables; Mantel-Haenszel chi-square for ordinal variables.
ANOVA 5 analysis of variance; LAD 5 left anterior descending coronary artery; MI 5 myocardial infarction.
Table 4. Unadjusted Rates of In-hospital Outcomes by Terciles of Annual Operator
Procedure Rates
Characteristic
Terciles
Low
(n 5 2,082)
Middle
(n 5 4,046)
High
(n 5 8,370)
Clinical success† (%) 91.3 (90.0, 92.4)* 89.2 (88.8, 90.2) 90.4 (89.8, 91.0)
MI (%) 2.5 (1.8, 3.2) 1.9 (1.5, 2.4) 1.9 (1.6, 2.2)
Any CABG (%) 2.1 (1.5, 2.8) 2.8 (2.4, 3.4) 2.7 (2.3, 3.0)
Emergency (%) 1.7 (1.2, 2.4) 2.1 (1.6, 2.5) 1.7 (1.5, 2.0)
Nonemergency (%) 0.4 (0.2, 0.9) 0.8 (0.5, 1.1) 0.9 (0.7, 1.2)
Death (%)
Low-risk patients 0.4 (0.2, 0.8) 0.4 (0.2, 0.6) 0.8 (0.6, 1.0)
High-risk patients‡ 5.3 (2.4, 9.8) 5.0 (3.0, 7.7) 7.8 (6.0, 9.9)
*95% confidence interval; †$1 lesion dilated to ,50% and no MI, CABG, death; ‡High-risk: priority 5 emergent or
indication 5 primary PCI for treatment of MI or treatment of shock.
CABG 5 coronary artery bypass grafting surgery; MI 5 myocardial infarction.
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between operator volume and the adverse outcome of
CABG. Why the difference between our previous study and
the current one? It is not a consequence of changing
case-mix (intervening on patients who are at lower risk for
an adverse outcome). Using a clinical prediction rule devel-
oped on 1994–1996 data, the average expected mortality
has actually increased from 0.71% in 1990–1993 to 1.16%
in 1994–1996, indicating that the more recent patient
population is at higher risk for adverse events. It was not the
influx of new operators into the region (see above). The
average number of procedures performed by low tercile
operators was slightly higher in the current study (mean 5
68, median 5 75) than in the previous study (mean 5 62,
median 5 68), though it is hard to imagine that such a small
increment in average volumes could make such a difference.
Hannan et al. (6) reported an interaction between
operator and institutional volumes and showed that low
volume operators (,75 procedures per year) working in
high volume hospitals ($600 procedures per hospital per
year) have good results. We cannot rule out such an effect
because in 1994 to 1996 only 3% of the patients under-
went an intervention at a hospital performing ,600
procedures per hospital per year by a low or moderate
volume operator compared with 21.8% in 1990 –1993.
We cannot rule out increased cumulative experience on
the part of operators or hospitals as contributing to the
improvement in outcomes for all interventionists regard-
less of their annual volume, though this was not the case
in one previous study (7). It is possible that our ongoing
regional efforts at examining the process and outcomes of
care (30) have resulted in improvement, as was the case
for the regional study of CABG (22). These efforts
include the timely feedback of accurate data on process
and outcomes, regional meetings three times a year to
Figure 1. The changing use of coronary stents in northern New England from 1994–1996 by tercile of annual operator volume.
Table 5. Adjusted Rates of In-hospital Outcomes by Terciles of Annual Operator Procedure Rates
Characteristic
Terciles
p-Trend
Low
(n 5 2,082)
Middle
(n 5 4,046)
High
(n 5 8,370)
Clinical success† (%) 90.92 (89.69, 92.15)* 88.84 (87.86, 89.81) 90.70 (90.10, 91.30) 0.237
MI (%) 2.57 (1.87, 3.27) 1.90 (1.48, 2.33) 1.86 (1.58, 2.15) 0.065
Any CABG (%) 2.17 (1.54, 2.81) 2.85 (2.34, 3.36) 2.64 (2.30, 2.97) 0.560
Emergency (%) 1.74 (1.18, 2.31) 2.05 (1.62, 2.49) 1.75 (1.48, 2.03) 0.733
Nonemergency (%) 0.44 (0.13, 0.74) 0.80 (0.53, 1.08) 0.90 (0.70, 1.09) 0.051
Death (%)
Low-risk patients 0.45 (0.14, 0.77) 0.41 (0.20, 0.62) 0.71 (0.53, 0.90) 0.086
High-risk patients‡ 5.68 (2.18, 9.18) 5.99 (3.51, 8.46) 7.23 (5.59, 8.86) 0.324
*95% confidence interval; †$1 lesion dilated to ,50% and no MI, CABG, death; ‡High risk: priority 5 emergent or indication 5 primary PCI for treatment of MI or treatment
of shock.
CABG 5 coronary artery bypass grafting surgery; MI 5 myocardial infarction.
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discuss the data and an analysis of the proximate cause of
death in a large, regional cohort of 12,232 patients (31).
The influence of stenting. Could the introduction of
stents have something to do with our findings? The use of
stents reduces the need for eCABG surgery (32–34) and
may increase clinical success rates (35). In northern New
England, their use grew dramatically during the study
period and interventionists in the lower volume terciles were
more likely to use them (Fig. 1) than those in the highest
volume tercile (reflecting primarily a practice pattern). All
interventionists in the region had stents available to them
for use with suboptimal results. Though the use of stents
represents an operator characteristic and, therefore, was not
a variable we chose to adjust for when testing the volume-
outcome relationship, it could help to explain the rela-
tionship. However, when stent was entered into the
multivariate model, the relationship between operator vol-
ume and outcome did not change and was still insignificant.
We do not yet know what effect stents might have as their
increased usage by high volume operators becomes compa-
rable with that of lower volume operators or their overall
rate of use increases. Other devices and the newer antiplate-
let agents were not used with any great frequency during
this time period and were not significantly associated with
any outcomes.
Other studies. There have been three other recent studies
based on registry or multicenter data that have explicitly
examined the relationship between operator volume and
outcomes. Using 1992 Medicare discharge abstracts, Jollis et
al. (5) demonstrated an inverse relationship between post-
PCI rates of CABG and operator volume. Hannan et al. (6)
used 1991 to 1994 New York State clinical data and found
an inverse relationship between operator volume and both
the outcomes of in-hospital death and CABG. Ellis et al.
(7) examined 1993 to 1994 data from five high-volume
centers and determined that death and the composite end
point of death, Q-wave MI or eCABG, were inversely
related to the number of cases each operator performed
annually. The difference in findings between these studies
and our study may be a consequence of our procedure rates
for the low volume operators being higher than in other
studies, our use of more recent data reflecting the ongoing
changes in interventional cardiology or a finding that is
unique to the somewhat more conservative practice patterns
in northern New England (36).
Study limitations. Our study has several limitations. Com-
pared with other parts of the country, our low volume
operators are not truly “low volume” and our hospitals are
high volume institutions (.600 procedures per year). Using
1992 national data, Jollis et al. (5) estimated that the average
annual volume of procedures for an interventionist was 26 to
39 and was 196 to 294 for hospitals. Therefore, our results
may not be generalizable to operators or hospitals with
lower annual volumes. The data on MIs was not validated.
High volume operators, who use more devices, may be more
likely to measure postprocedure cardiac enzymes and, as a
consequence, to find and report MIs. This might obscure a
finding of increased MI rates in low volume operators. Our
results are limited to in-hospital outcomes. We cannot
comment on the important long-term outcomes of target
lesion revascularization and functional status. Finally, the
practice of interventional cardiology continues to change.
The use of stents is growing and new antiplatelet agents are
being used with increased frequency. What effect this will
have on practice and outcomes and their relationship to
operator volume is not yet known.
Some may question why we chose to analyze death after
stratifying patients into those at low versus high risk of an
adverse event. In previous work (28) we determined that
predicting the risk of dying post-PCI was least precise for
the patients who had the highest risk of dying. Therefore,
we chose to improve our ability to control for confounding
by stratifying the data based on risk. The data also suggested
this was a good idea because 32.6% of all deaths occurred
among patients in cardiogenic shock and shock patients
were 2.7 times as likely to be cared for by high volume
operators than by lower volume operators. Repeating the
analysis after eliminating patients in cardiogenic shock and
not stratifying death by predicted patient risk did not
change our results.
The ACC recommendations. Our findings do not negate
the recent recommendations made by the ACC (15),
suggesting that to maintain optimal proficiency in coronary
interventions, physicians should be performing $75 proce-
dures per year. Though the average volume of procedures in
our lowest tercile (n 5 68) was slightly below that limit, the
median volume was 75. Our somewhat small sample size
(47 operators) precluded us from eliminating the operators
with rates below 75. However, the ACC recommendations
suggest that it may also be acceptable for operators with
annual volumes of 50 to 75 to perform coronary interven-
tions if they work at high volume hospitals performing
.600 procedures per year (as was the case in our study) and
if they are “cautious in case selection.” Repeating our
analysis after eliminating the three operators with volumes
,50 did not change our results. It should be made clear that
our findings cannot be extended to operators with even
lower volumes, or working in lower volume hospitals, until
the outcomes for this group of physicians are assessed. It
continues to make sense that, to maintain the skills and
judgment necessary for good outcomes, some minimal level
of annual experience is important.
Conclusions. We conclude that in the modern era of
interventional cardiology, after adjusting for case-mix and
severity of illness, outcomes are comparable for providers
across a spectrum of annual operator volumes. It remains to
be seen whether these findings are generalizable beyond
northern New England, for providers with lower annual
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volumes than the physicians in our study and in hospitals
with lower annual volumes, whether they hold for long-
term outcomes and what happens as the practice of inter-
ventional cardiology continues to evolve.
APPENDIX A
Logistic Regression Models for Each Outcome Variable:
1. Clinical success: Age, diabetes mellitus, peripheral vas-
cular disease, creatinine .2 mg/dL, heparin before
procedure, intraaortic balloon pump before procedure,
number of diseased coronary arteries, indication, priority,
American College of Cardiology (ACC) lesion type.
2. In-hospital death: Age, peripheral vascular disease, cre-
atinine .2 mg/dL, indication, priority, ejection fraction,
congestive heart failure, intraaortic balloon pump before
procedure, ACC lesion type.
3. CABG: Age, diabetes mellitus, congestive heart failure,
prior PCI, prior CABG, number of diseased coronary
arteries, priority, ACC lesion type, intervention on the
proximal left anterior descending coronary artery.
4. Emergency CABG: Age, diabetes mellitus, congestive
heart failure, prior PCI, prior CABG, number of dis-
eased coronary arteries, priority, ACC lesion type.
5. Non-emergency CABG: Age, diabetes mellitus, chronic
obstructive pulmonary disease, prior MI, prior PCI,
indication, number of diseased coronary arteries, priority,
ACC lesion type.
6. Myocardial infarction: Prior PCI, intervention on a
bypass graft, ACC lesion type.
APPENDIX B
Members of the Northern New England Cardiovascular
Disease Study Group
Beth Israel-Deaconess Medical Center: Mary Bogosian,
RN, CCP, David Brackett, RN, Christian Campos, MD,
Jeannie Fischer, PA, Philip J. Fitzpatrick, MD, Beth
Jennings, RN, Robert Johnson, MD, Wendy Kowalker,
RN, Patricia Lahey, RN, Stephen J. Lahey, MD, David
Leeman, MD, David Leeman, MD, Keith P. Lewis, MD,
Stanley Lewis, MD, Maria Lustenberger, RN, Peter R.
Maggs, MD, Richard Nesto, MD, Brian O’Connor, CCP,
Patty Pawlow, RN, Kathy Peterson, RN, Patricia Rabett,
RN, Cheryl Sirois, RN, Samuel Shubrooks, MD, Terri
Stokes, RN, MS, Susan Sumner, RN, Paul G. Vivino, MD,
Albert Washko, MD, Ronald Weintraub, MD.
Dartmouth Hitchcock Medical Center: Lindsay
D’Anna, PA, Virginia Beggs, ARNP, MS, John D. Birk-
meyer, MD, Nancy J. O. Birkmeyer, PhD, William Burke,
RCVT, Edward Catherwood, MD, MS, Mike Chamber-
lain, RN, Lawrence J. Dacey, MD, MS, Gordon Defoe,
CCP, Kenneth Dixon-Vestal, RN, Thomas Dodds, MD,
Mary Fillinger, MD, Bruce Friedman, MD, Christine
Heins, RN, Bruce Hettleman, MD, Douglas James, MD,
John E. Jayne, MD, Karen A. Jean, RN, Pamela Jenkins,
MD, Joseph Kasper, ScD, Lori Key, RN, Terry Kneeland,
MPH, Judith Kobe, RN, Elizabeth Maislen, ARNP, David
J. Malenka, MD, Charles, A. S. Marrin, MB, BS, Mary-
Menduni, RN, Nathaniel Niles, MD, William C. Nugent,
MD, Gerald T. O’Connor, PhD., DSc, Elaine M. Olm-
stead, BA, Daniel O’Rourke, MD, Winthrop Piper, MS,
Stephen K. Plume, MD, Hebe B. Quinton, MS, John
Robb, MD, Cathy S. Ross, MS, John Sanders, MD,
William Schults, William F. Sullivan, MS, Jon Wahren-
berger, MD, Beth Wolf, MBA.
Eastern Maine Medical Center: Robert Allen, MD, Jim
Blum, MS, Deborah Carey-Johnson, RN, MS, Chae C.
Choi, MD, Tina Closson, RN, Robert Clough, MD,
Donna Dauphinee, RN, Cynthia M. Downs, RN, MSN,
Glen D. Garson, MD, Felix Hernandez, Jr., MD, Rebecca
Henry, RN, Joseph J. Hessel, MD, Robert M. Hoffman,
MD, John H. Jentzer, MD, Edward R. Johnson, MD, Peter
Marshall, MD, Helen McKinnon, RN, Cathy Mingo, RN,
MS, Craig Pedersen, PA, Wendy Perkins, LPN, Robert
Rosenthal, MD, Matthew W. Rowe, MD, Katrina Sargent,
BA, M. Theodore Silver, MD, Sherry Spraque, Wolfgang
J.T. Spyra, MD, Laurie True, RN, Peter Ver Lee, MD,
Paul vom Eigen, MD, Craig Warren, CCP.
Fletcher Allen Health Care: Richard G. Brandenburg,
PhD, Pamela Brown, RN, Betsy Burns, RN, Mark Cape-
less, MD, Kevin Carey, MD, Steve Colmanaro, PA, Steve
Crumb, RN, CS, Betty Diette, RN, Roy V. Ditchey, MD,
Maureen Dwyer, ARNP, Karen Farrell, ANP, Jan Faucett,
RN, Sally Gagnon, RN, Susan Geoffrey, RN, Larry Goets-
chius, MBA, Laurie Grenier, RN, Walter D. Gundel, MD,
Richard S. Jackson, MD, David Johnson, MD, Charlie
Krumholz, CCP, Ann Laramee, RN, Bruce J. Leavitt, MD,
Martin Lewinter, MD, Steve Marcus, PA, Karen Mc-
Kenny, RN, Mitchell Norotsky, MD, Madeline Norse, RN,
William C. Paganelli, MD, PhD, Diane Pappalardo,
MHSA, Daniel S. Raabe, MD, Melinda Rabideau, RN,
Martha Root, RN, Janice Smith, RN, Christopher M.
Terrien Jr., MD, Edward Terrien, MD, Matthew W.
Watkins, MD, Jane Wilde, RN, MSN, William Witmer,
MD.
Maine Medical Assessment Foundation: Robert B.
Keller, MD, David C. Soule (Deceased), MPH, David
Wennberg, MD, MPH.
Maine Medical Center: Lawrence Adrian, PA, Warren
D. Alpern, MD, Eric Anderson, BA, Richard A. Anderson,
MD, Linda Banister, RN, Claire Berg, RN, Seth Blank,
MD, John Braxton, MD, Carl E. Bredenberg, MD, Mi-
chael Brennan, PA, David Burkey, MD, Cantwell Clark,
MD, Jane Cleaves, RN, Vincent Conti, CEO, Deborah
Courtney, RN, MS, Joshua Cutler, MD, Desmond
Donegan, MD, Pat Fallo, RN, Rick Forest, CCP, Robert
Groom, CCP, Daniel Hanley, MD, Mary Beth Hourihan,
MD, Jane Kane, RN, Saul Katz, MD, Mirle A. Kellett, Jr.,
MD, Robert Kramer, MD, Costas T. Lambrew, MD, F.
Stephen Larned, MD, Lee Lucas, PhD, Paul D. McGrath,
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MD, Jeremy R. Morton, MD, Edward R. Nowicki, MD,
John R. O’Meara, MD, Sheilia Parker, RN, Patricia Peas-
ley, RN, Cathy Prouty, RN, Reed D. Quinn, MD, Dennis
Redfield, BA, Karen Reynolds, MPH, Thomas Ryan Jr.,
MD, Jean Saunders, MSN, MPH, Alyce Schultz, RN,
PhD, Susan Seekins, RN, Paul W. Sweeney, MD, Karen
Tolan, RN, Nancy Tooker, RN, Joan F. Tryzelaar, MD,
Paul T. Vaitkus, MD, Kathy Viger, RN, Cynthia
Westlund, RN, Wanda Whittet, RN.
Catholic Medical Center: Yvon Baribeau, MD, Ann
Becker, RN, Craig C. Berry, MD, Kevin Berry, MD,
William A. Bradley, MD, David C. Charlesworth, MD,
Susan Cuddy, RN, Robert C. Dewey, MD, Frank Fedele,
MD, Louis I. Fink, MD, Erik J. Funk, MD, Alan E.
Garstka, MD, Karen Grafton, RN, Dan Halstead, CCP,
Michael J. Hearne, MD, J. Beatty Hunter, MD, Alan D.
Kaplan, MD, Dennis Kelly, MD, Mark A. Klinker, MD,
Peggy Lambert, RN, Patrick J. Lawrence, MD, Jeffery
Lockhart, MD, Christopher T. Maloney, MD, Kathy
McNeil, RN, Venkatram Nethala, MD, Edward Palank,
MD, John Pieroni, CCP, M. Judith Porelle, RN, Joanne
Robichaud, RN, Mary Sanford, RN, James Schnitz, MD,
Benjamin M. Westbrook, MD, Thomas P. Wharton, MD,
Kirke W. Wheeler, MD, Diane White, RN.
Reprint requests and correspondence: David J. Malenka, Section
of Cardiology, Dartmouth-Hitchcock Medical Center, Lebanon,
New Hampshire 03756. E-mail: david.malenka@hitchcock.org.
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